Multi-View Variational Autoencoder for Missing Value Imputation in Untargeted Metabolomics

, , , , Background: Missing data is a common challenge in mass spectrometry-based metabolomics, which can lead to biased and incomplete analyses. The integration of whole-genome sequencing (WGS) data with metabolomics data has emerged as a promising approach to enhance the accuracy of data imputation in metabolomics studies. Previous research has highlighted the importance of multi-omics data integration for identifying biomarkers and understanding disease mechanisms [17]. Leveraging information from WGS data and reference metabolites, a novel method utilizing a multi-view variational autoencoder was proposed to impute unknown metabolites based on genomic information. Method: To investigate genetic and environmental risk factors for osteoporosis and musculoskeletal diseases, the study enrolled 1,110 subjects from the Louisiana Osteoporosis Study (LOS) who had both WGS and metabolomics data [16]. The detailed procedure for WGS involved sequencing human peripheral blood DNA with an average read depth using a BGISEQ-500 sequencer. For feature extraction and missing metabolomics data imputation, the proposed method utilized burden score, polygenic risk score (PGS), and linkage disequilibrium (LD) pruned single nucleotide polymorphisms (SNPs). Figure 1 illustrates the architecture of the multi-view variational autoencoder used for this purpose. Results: Evaluation of the method on empirical metabolomics datasets with missing values demonstrated its superiority over conventional imputation techniques. By incorporating 35 template metabolites derived from burden scores, PGS, and LD-pruned SNPs, the proposed method achieved R^2-scores > 0.01 for 71.55% of metabolites. This performance improvement showcases the effectiveness of integrating WGS data in metabolomics imputation. Conclusion: The integration of WGS data not only enhances data completeness but also improves downstream analyses in precision medicine research. By leveraging multi-modal data integration, researchers can conduct more comprehensive and accurate investigations into metabolic pathways and disease associations. This study offers valuable insights into the potential benefits of utilizing WGS data for metabolomics imputation, emphasizing the importance of incorporating genomic information in advancing precision medicine approaches. Additionally, previous studies have emphasized the power and predictive accuracy of polygenic risk scores [23], highlighting their relevance in enhancing our understanding of complex diseases through multi-omic approaches.

Title: Integrating Whole-Genome Sequencing Data for Improved Metabolomics Imputation: A Multi-Omics Approach to Precision Medicine

Introduction: Mass spectrometry-based metabolomics is a powerful tool for identifying biomarkers and understanding disease mechanisms. However, missing data is a common challenge in these studies, which can lead to biased and incomplete analyses. To address this issue, researchers have turned to the integration of whole-genome sequencing (WGS) data with metabolomics data as a promising approach. This article will delve into a recent research paper that explores the use of multi-view variational autoencoder for imputing unknown metabolites based on genomic information.

The Louisiana Osteoporosis Study (LOS) enrolled 1,110 subjects who had both WGS and metabolomics data. The WGS procedure involved sequencing human peripheral blood DNA using a BGISEQ-500 sequencer with an average read depth.

Method: To extract features and impute missing metabolomics data, the proposed method utilized burden score, polygenic risk score (PGS), and linkage disequilibrium (LD) pruned single nucleotide polymorphisms (SNPs). These elements were incorporated into a multi-view variational autoencoder architecture shown in Figure 1.

Results: Evaluation of the method on empirical metabolomics datasets with missing values demonstrated its superiority over conventional imputation techniques. By incorporating 35 template metabolites derived from burden scores, PGS, and LD-pruned SNPs, the proposed method achieved R^2-scores > 0.01 for 71.55% of metabolites.

Conclusion: This study highlights the potential benefits of integrating WGS data in improving accuracy and completeness in mass spectrometry-based metabolomics studies. The use of multi-modal data integration allows for more comprehensive and accurate investigations into metabolic pathways and disease associations, ultimately advancing precision medicine approaches. Additionally, the study emphasizes the power and predictive accuracy of polygenic risk scores, further highlighting their relevance in understanding complex diseases through multi-omic approaches.

Implications: The integration of WGS data not only enhances data completeness but also improves downstream analyses in precision medicine research. By leveraging multi-omics data, researchers can gain a deeper understanding of the genetic and environmental factors contributing to complex diseases such as osteoporosis and musculoskeletal disorders. This approach has the potential to lead to more targeted and effective treatments for these conditions.

Future Directions: While this study showcases the effectiveness of integrating WGS data in metabolomics imputation, there is still room for improvement. Further research could explore incorporating additional types of omics data such as transcriptomics or proteomics to enhance imputation accuracy even further. Additionally, investigating different machine learning algorithms or methods for feature extraction could potentially improve results.

By utilizing a multi-view variational autoencoder architecture with burden score, PGS, and LD-pruned SNPs, they were able to achieve superior imputation performance compared to conventional techniques. This approach has significant implications for precision medicine research by providing a more comprehensive understanding of disease mechanisms and potential treatment options through multi-omic approaches.